11.04.2019
- Danish drugmaker Novo Nordisk plans to invest 650 million krone, or $98 million, to upgrade and expand facilities at its site in Kalundborg. The plants currently manufacture a...
15.03.2019
- Under the name INNOVO, Danish diabetes giant Novo Nordisk has launched an innovation platform for China in a drive to accelerate the transformation of scientific research into new...
16.01.2019
- Denmark’s Novo Nordisk Pharmatech has partnered with the Performance Materials business unit of DKSH, a major ingredients and specialty chemicals distributor specializing in Asia...
29.11.2018
- As part of its journey toward being a full-fledged advanced economy, the role and presence of China within the pharmaceutical industry has rapidly evolved throughout the recent...
13.09.2018
- Ossianix, a privately held US pharmaceutical research firm based in Philadelphia, Pennsylvania, has entered a research collaboration and option agreement with Danish drugmaker Novo...
27.08.2018
- Danish pharma Novo Nordisk is boosting its efforts to develop the world’s first glucose responsive insulin and transform the treatment of diabetes following its purchase of Ziylo...
25.06.2018
- Danish drugmaker Novo Nordisk is collaborating with Kallyope, a US biotech focused on the gut-brain axis, to discover novel peptide therapeutics for obesity and diabetes. Kallyope...
11.06.2018
- Drugmaker Novo Nordisk plans to cut as many as 3,000 jobs and may reduce its financial guidance, according to a report in the Danish financial newspaper Borsen. The paper, citing...
